Immediate Impact

35 by Nobel laureates 32 from Science/Nature 85 standout
Sub-graph 1 of 20

Citing Papers

mTOR substrate phosphorylation in growth control
2022 Standout
Challenges and Opportunities in Cancer Drug Resistance
2020 Standout
37 intermediate papers

Works of Kim Arndt being referenced

SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice.
2003
TIP41 Interacts with TAP42 and Negatively Regulates the TOR Signaling Pathway
2001
and 6 more

Author Peers

Author Last Decade Papers Cites
Kim Arndt 3571 637 603 58 4.5k
Alexandr P. Kornev 4519 625 847 65 5.5k
Klaus Scheffzek 5166 984 1452 78 7.0k
Mark S. Dennis 2701 844 264 52 4.8k
David J. Bearss 4885 1453 643 114 6.4k
Roy M. Pollock 5370 627 216 54 6.2k
Natarajan Kannan 3148 453 802 118 4.2k
Christin Tse 3425 869 216 24 4.2k
Janusz M. Sowadski 3878 837 706 47 4.6k
Katherine L. B. Borden 6567 922 417 117 8.1k
Francis Burrows 4877 1121 817 107 6.4k

All Works

Loading papers...

Rankless by CCL
2026